Download the results highlights (PDF)

Download the full results (PDF)

A year of consistently strong growth

• Total return of £5,049 million or 25% on opening shareholders’ funds (2024: £3,839 million, 23%) and NAV per share of 2,542 pence (31 March 2024: 2,085 pence). This includes a 27 pence per share loss on foreign exchange translation.
  
  
• Our Private Equity business delivered a gross investment return (“GIR”) of £5,113 million or 26% (2024: £4,059 million, 25%). This result was driven primarily by Action’s continued strong performance in FY2025. Royal Sanders, our other longer-term hold investment, also produced a very strong return, driven by organic and acquisitive growth. We saw good growth across several of our other consumer and private label, industrial and healthcare portfolio companies.Trading in our services and software portfolio has been resilient, despite a cautious IT spending environment. Market-specific challenges continue to impact a small number of portfolio companies.
  
  
• Action generated a GIR of £4,551 million, or 32%, on its opening value. It delivered annual revenue growth of 22%, like-for-like (“LFL”) sales growth of 10.3% and EBITDA growth of 29% in 2024. The business has started 2025 well, with net sales of €3,521 million (first three periods of 2024: €3,004 million), operating EBITDA of €464 million (first three periods of 2024: €397 million) and LFL sales growth of 6.2% in the first three periods of 2025 (P3 2025 which ended on 30 March 2025). The LTM run-rate EBITDA to P3 2025, totalled €2,328 million (LTM run-rate EBITDA to 31 March 2024: €1,848 million), representing a 26% increase on the same period last year. This strong performance supported value growth of £4,324 million for Action in the year, in addition to realised proceeds and dividend distributions to 3i of £1,597 million.
  
  
• At the end of week 19 (11 May 2025), Action’s year-to-date LFL sales growth was 6.8% and 76 new stores had been added. At that date, Action’s cash balance was €427 million.
  
  
• The Private Equity team invested £1,177 million in the year, including £768 million in a further stake in Action, £318 million in new investments in Constellation, WaterWipes and OMS Prüfservice, £39 million in a further investment in Royal Sanders and £54 million in the further development of ten23 health. Our Private Equity portfolio companies completed 12 bolt-on acquisitions, only one of which required further funding from 3i.
  
  
• The Private Equity team generated £659 million of realised proceeds from the realisations of nexeye and WP, both generating money multiples of 2.0x or higher.
  
  
• Our Infrastructure business generated a GIR of £52 million, or 3% (2024: £99 million, 7%). This performance was driven principally by a good level of dividend and interest income alongside value growth from our infrastructure funds, which more than offset subdued share price performance from our 29% stake in 3i Infrastructure plc (“3iN”).
  
  
• In total across the Group, we received £2.4 billion of cash proceeds from the portfolio. We ended the year with liquidity of £1,323 million, net debt of £771 million and gearing of 3%.
  
  
• Total dividend of 73.0 pence per share for FY2025, with a second FY2025 dividend of 42.5 pence per share to be paid in July 2025 subject to shareholder approval.
  

Simon Borrows, 3i's Chief Executive, commented:

“FY2025 was another successful year for 3i, continuing our track record of consistently delivering strong shareholder returns, against what remains a challenging macro-economic and geopolitical backdrop.

Our FY2025 result was underpinned by the powerful compounding growth from our long-term hold assets Action and Royal Sanders, and by the performance of several other larger portfolio companies. This reinforces our conviction in allocating additional capital to our best performing assets. We remain confident in our ability to compound growth across the portfolio in the years to come.”

Financial highlights

¹ _{Gearing is net debt as a percentage of net assets.}

-ENDS-

For further information, please contact:

For further information regarding the announcement of 3i’s annual results to 31 March 2025, including a live webcast of the results presentation at 10.00am, please visit www.3i.com.